Cleo Diagnostics Ltd (ASX:COV)
Australia
· Delayed Price · Currency is AUD
0.530
+0.025 (4.95%)
Last updated: Mar 10, 2026, 1:51 PM AEST
Cleo Diagnostics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
| Cash & Equivalents | 9.43 | 6.46 | 9.37 | 0.24 |
| Cash & Short-Term Investments | 9.43 | 6.46 | 9.37 | 0.24 |
| Cash Growth | 28.94% | -31.07% | 3809.00% | - |
| Other Receivables | 0.1 | 0.07 | 0.06 | 0.03 |
| Receivables | 0.1 | 0.07 | 0.06 | 0.03 |
| Prepaid Expenses | 0.08 | 0.01 | 0.01 | 0.31 |
| Total Current Assets | 9.6 | 6.55 | 9.44 | 0.58 |
| Property, Plant & Equipment | 0.03 | 0.03 | 0.03 | 0.04 |
| Other Intangible Assets | 0.33 | 0.36 | 0.41 | 0.46 |
| Accounts Payable | 1.01 | 0.87 | 0.27 | 0.31 |
| Accrued Expenses | 0.13 | 0.1 | 0.05 | 0 |
| Short-Term Debt | - | - | - | 1.6 |
| Other Current Liabilities | - | 0.13 | 0.17 | 0.1 |
| Total Current Liabilities | 1.14 | 1.1 | 0.49 | 2.02 |
| Common Stock | 18.09 | 13.71 | 13.71 | 0.05 |
| Retained Earnings | -11.52 | -9.53 | -5.53 | -1.77 |
| Comprehensive Income & Other | 2.25 | 1.66 | 1.22 | 0.78 |
| Total Liabilities & Equity | 9.96 | 6.94 | 9.88 | 1.08 |
| Total Debt | - | - | - | 1.6 |
| Net Cash (Debt) | 9.43 | 6.46 | 9.37 | -1.36 |
| Net Cash Growth | 28.94% | -31.07% | - | - |
| Net Cash Per Share | 0.07 | 0.05 | 0.08 | -0.05 |
| Filing Date Shares Outstanding | 136.86 | 128.5 | 128.5 | 44.09 |
| Total Common Shares Outstanding | 136.86 | 128.5 | 128.5 | 44.09 |
| Working Capital | 8.46 | 5.44 | 8.95 | -1.44 |
| Book Value Per Share | 0.06 | 0.05 | 0.07 | -0.02 |
| Tangible Book Value | 8.49 | 5.48 | 8.98 | -1.4 |
| Tangible Book Value Per Share | 0.06 | 0.04 | 0.07 | -0.03 |
| Machinery | - | 0.05 | 0.04 | 0.04 |
Source: S&P Capital IQ. Standard template.
Financial Sources.